Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
C Rodrigo, S Rajapakse… - Cochrane Database of …, 2020 - cochranelibrary.com
Background Plasmodium vivax malaria has a persistent liver stage that causes relapse of
the disease and continued P vivax transmission. Primaquine (PQ) is used to clear the liver …
the disease and continued P vivax transmission. Primaquine (PQ) is used to clear the liver …
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
S Rajapakse, C Rodrigo… - Cochrane database of …, 2015 - cochranelibrary.com
Background Plasmodium vivax malaria is widespread, and the persistent liver stage causes
relapse of the disease which contributes to continued P. vivax transmission. Primaquine is …
relapse of the disease which contributes to continued P. vivax transmission. Primaquine is …
Primaquine for preventing relapses in people with Plasmodium vivax malaria
GNL Galappaththy, AAA Omari… - Cochrane Database of …, 2007 - cochranelibrary.com
Primaquine for preventing relapses in people with Plasmodium vivax malaria - Galappaththy,
GNL - 2007 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve …
GNL - 2007 | Cochrane Library Skip to Content Cookies Our site uses cookies to improve …
Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
Background Malaria caused by Plasmodium vivax requires treatment of the blood‐stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine
GNL Galappaththy, P Tharyan… - Cochrane Database of …, 2013 - cochranelibrary.com
Background Plasmodium vivax infections are an important contributor to the malaria burden
worldwide. The World Health Organization recommends a 14‐day course of primaquine …
worldwide. The World Health Organization recommends a 14‐day course of primaquine …
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
R Milligan, A Daher, G Villanueva… - Cochrane Database …, 2020 - cochranelibrary.com
Background Plasmodium vivax liver stages (hypnozoites) may cause relapses, prolonging
morbidity, and impeding malaria control and elimination. The World Health Organization …
morbidity, and impeding malaria control and elimination. The World Health Organization …
Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis
MU Anjum, AK Naveed, SN Mahmood… - Travel Medicine and …, 2020 - Elsevier
Background Plasmodium vivax is a frequent cause of recurring malaria in endemic areas as
in its latent stage it resides in liver, and is responsible for relapse. Treatment with 8 …
in its latent stage it resides in liver, and is responsible for relapse. Treatment with 8 …
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
A Llanos-Cuentas, MVG Lacerda, TT Hien… - … England Journal of …, 2019 - Mass Medical Soc
Background Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been
associated with relapse prevention through the clearance of P. vivax parasitemia and …
associated with relapse prevention through the clearance of P. vivax parasitemia and …
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
AB Hounkpatin, A Kreidenweiss… - Infection and drug …, 2019 - Taylor & Francis
Tafenoquine is an 8-aminoquinoline with activity against all human life cycle stages of
Plasmodium vivax, including dormant liver stages–so called hypnozoites. Its long half-life …
Plasmodium vivax, including dormant liver stages–so called hypnozoites. Its long half-life …
Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
A single 300 mg dose of tafenoquine, in combination with chloroquine, is currently approved
in several countries for the radical cure (prevention of relapse) of Plasmodium vivax malaria …
in several countries for the radical cure (prevention of relapse) of Plasmodium vivax malaria …